革兰氏阴性杆菌对庆大霉素和妥布霉素是否存在完全交叉耐药性？
Is there complete cross-resistance of gram-negative bacilli to gentamicin and tobramycin?
作者信息
Crowe C C, Sanders E
出版信息
Antimicrob Agents Chemother. 1972 Nov;2(5):415-6. doi: 10.1128/AAC.2.5.415.
Abstract
No cross-resistance between gentamicin and tobramycin was found among 19 recent clinical isolates representing four genera of gram-negative bacilli.
摘要
在代表革兰氏阴性杆菌四个属的19株近期临床分离株中，未发现庆大霉素和妥布霉素之间存在交叉耐药性。
相似文献
1
Is there complete cross-resistance of gram-negative bacilli to gentamicin and tobramycin?革兰氏阴性杆菌对庆大霉素和妥布霉素是否存在完全交叉耐药性？
Antimicrob Agents Chemother. 1972 Nov;2(5):415-6. doi: 10.1128/AAC.2.5.415.
2
In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.庆大霉素和/或妥布霉素耐药革兰氏阴性杆菌对七种氨基糖苷类药物的体外敏感性
Infection. 1978;6(3):111-5. doi: 10.1007/BF01642258.
3
A laboratory assessment of the activities of four aminoglycosides.四种氨基糖苷类药物活性的实验室评估
S Afr Med J. 1984 Jun 9;65(23):922-4.
4
Gentamicin and tobramycin--an in vitro comparison using 1400 clinical isolates.庆大霉素与妥布霉素——使用1400株临床分离菌株的体外比较
Pathology. 1976 Jul;8(3):195-9. doi: 10.3109/00313027609058999.
5
Frequency of resistance to kanamycin, tobramycin, netilmicin, and amikacin in gentamicin-resistant gram-negative bacteria.庆大霉素耐药革兰氏阴性菌对卡那霉素、妥布霉素、奈替米星和阿米卡星的耐药频率。
Antimicrob Agents Chemother. 1978 Jan;13(1):70-3. doi: 10.1128/AAC.13.1.70.
6
[Resistance to aminoglycosides among gram - negative bacteria].[革兰氏阴性菌对氨基糖苷类抗生素的耐药性]
Mikrobiyol Bul. 1982 Jan;16(1):1-4.
7
8
Antimicrobial activity in vitro of netilmicin and comparison with sisomicin, gentamicin, and tobramycin.奈替米星的体外抗菌活性及其与西索米星、庆大霉素和妥布霉素的比较。
Antimicrob Agents Chemother. 1977 Jan;11(1):118-21. doi: 10.1128/AAC.11.1.118.
9
Gentamicin and tobramycin resistant gram-negative bacilli in a community hospital.
Infect Control. 1980 Jul-Aug;1(4):249-52. doi: 10.1017/s0195941700053091.
10
Sisomicin: evaluation in vitro and comparison with gentamicin and tobramycin.西索米星：体外评价及其与庆大霉素和妥布霉素的比较
Antimicrob Agents Chemother. 1973 Jan;3(1):24-8. doi: 10.1128/AAC.3.1.24.
引用本文的文献
1
Trends, patterns and relationship of antimicrobial use and resistance in bacterial isolates tested between 2015-2020 in a national referral hospital of Zambia.2015-2020 年间赞比亚一家国家转诊医院测试的细菌分离株中抗菌药物使用和耐药性的趋势、模式和关系。
PLoS One. 2024 Apr 16;19(4):e0302053. doi: 10.1371/journal.pone.0302053. eCollection 2024.
2
Sisomicin: evaluation in vitro and comparison with gentamicin and tobramycin.西索米星：体外评价及其与庆大霉素和妥布霉素的比较
Antimicrob Agents Chemother. 1973 Jan;3(1):24-8. doi: 10.1128/AAC.3.1.24.
3
Comparative clinical study of tobramycin and gentamicin.妥布霉素与庆大霉素的对比临床研究
Antimicrob Agents Chemother. 1974 Feb;5(2):133-8. doi: 10.1128/AAC.5.2.133.
4
Clinical study of the use of the new aminoglycoside tobramycin for therapy of infections due to gram-negative bacteria.新型氨基糖苷类药物妥布霉素用于治疗革兰氏阴性菌感染的临床研究。
Antimicrob Agents Chemother. 1974 Jan;5(1):75-81. doi: 10.1128/AAC.5.1.75.
5
Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibiotics.BB-K8（阿米卡星）对耐一种或多种氨基糖苷类抗生素的临床分离株的活性。
Antimicrob Agents Chemother. 1974 Feb;5(2):143-52. doi: 10.1128/AAC.5.2.143.
6
Transferrable resistance to tobramycin in Klebsiella pneumoniae and Enterobacter cloacae associated with enzymatic acetylation of tobramycin.肺炎克雷伯菌和阴沟肠杆菌中与妥布霉素酶促乙酰化相关的可转移的妥布霉素耐药性。
Antimicrob Agents Chemother. 1974 Oct;6(4):492-7. doi: 10.1128/AAC.6.4.492.
7
Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa.妥布霉素、阿米卡星和庆大霉素单独及与羧苄西林联合使用对铜绿假单胞菌的比较活性
Antimicrob Agents Chemother. 1974 Oct;6(4):442-6. doi: 10.1128/AAC.6.4.442.
8
Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa.新型氨基糖苷类抗生素和羧苄青霉素单独及联合使用时对庆大霉素耐药铜绿假单胞菌的活性。
Antimicrob Agents Chemother. 1976 Sep;10(3):399-401. doi: 10.1128/AAC.10.3.399.
9
[Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].西索米星的抗菌效能。I：西索米星与庆大霉素、妥布霉素、阿米卡星和卡那霉素相比的体外活性（作者译）
Infection. 1976;4(2):35-41. doi: 10.1007/BF01638346.
10
Aminoglycoside cross-resistance patterns of gentamicin-resistant bacteria.耐庆大霉素细菌的氨基糖苷类交叉耐药模式。
J Clin Pathol. 1977 Aug;30(8):738-44. doi: 10.1136/jcp.30.8.738.
本文引用的文献
1
Structure of nebramycin factor 6, a new aminoglycosidic antibiotic.新氨基糖苷类抗生素暗霉素因子6的结构
Antimicrob Agents Chemother (Bethesda). 1970;10:309-13.
2
Preliminary studies with nebramycin factor 6.对新霉素因子6的初步研究。
Antimicrob Agents Chemother (Bethesda). 1970;10:314-21.
3
Cross-resistance of Pseudomonas to gentamicin and tobramycin.铜绿假单胞菌对庆大霉素和妥布霉素的交叉耐药性。
Antimicrob Agents Chemother. 1972 Mar;1(3):280-1. doi: 10.1128/AAC.1.3.280.
4
Evaluation of the in vitro activity of tobramycin as compared with that of gentamicin sulfate.与硫酸庆大霉素相比，妥布霉素体外活性的评估。
Appl Microbiol. 1972 Jan;23(1):4-7. doi: 10.1128/am.23.1.4-7.1972.
Zotero 插件